SCHEMBL5154772

SCHEMBL5154772

Oc1coc(O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5308709 0.71
SCHEMBL4472866 0.71
SCHEMBL14295009 0.71
SCHEMBL10265652 0.71
SCHEMBL10094142 0.71
SCHEMBL10094055 0.66
SCHEMBL13878998 0.66
SCHEMBL6827704 0.64
SCHEMBL243774 0.63 ALDH1A1 (0.55)
SCHEMBL9779717 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014200885-A1 PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2014-12-18 WO claimed
US-7297168-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-11-20 US claimed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
CN-107108554-B 1-cyclohexyl-2-phenylaminobenzimidazole as MIDH1 inhibitor for treating tumors 德国癌症研究中心 2020-11-06 CN disclosed
EP-3209660-B1 1-CYCLOHEXYL-2-PHENYLAMINOBENZIMIDAZOLES AS MIDH1 INHIBITORS FOR THE TREATMENT OF TUMORS DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (DE) 2020-06-17 EP disclosed
EP-3209660-B1 1-CYCLOHEXYL-2-PHENYLAMINOBENZIMIDAZOLES AS MIDH1 INHIBITORS FOR THE TREATMENT OF TUMORS DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (DE) 2020-06-17 EP disclosed
US-10137110-B2 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-11-27 US disclosed
CN-108368143-A Monomaleimide functionalized platinum compounds for cancer therapy 维也纳医科大学 2018-08-03 CN disclosed
US-20170319549-A1 1-CYCLOHEXYL-2-PHENYLAMINOBENZIMIDAZOLES AS MIDH1 INHIBITORS FOR THE TREATMENT OF TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-09 US disclosed
US-20170319549-A1 1-CYCLOHEXYL-2-PHENYLAMINOBENZIMIDAZOLES AS MIDH1 INHIBITORS FOR THE TREATMENT OF TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-09 US disclosed
US-20170319549-A1 1-CYCLOHEXYL-2-PHENYLAMINOBENZIMIDAZOLES AS MIDH1 INHIBITORS FOR THE TREATMENT OF TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-09 US disclosed
US-7297168-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-11-20 US disclosed
EP-1737417-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-01-03 EP disclosed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US disclosed
WO-2005074875-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-08-18 WO disclosed
US-4968594-A PYRAZOLOTRIAZOLE-BASED MAGENTA COUPLER AND MEANS FOR FORMING UNSHARP POSITIVE IMAGE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1990-11-06 US disclosed
EP-0174873-B1 SILVER HALIDE COLOR PHOTO-SENSITIVE MATERIAL KONICA CORPORATION (JP) 1988-11-17 EP disclosed
EP-0236131-A2 Silver halide color photographic material KONICA CORPORATION (JP) 1987-09-09 EP disclosed
US-4690888-A SLIGHTLY-DIFFUSABLE COLORED COMPOUNDS TO REACT WITH OXIDIZED DEVELOPERS; SHARPNESS KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1987-09-01 US disclosed
EP-0174873-A2 Silver halide color photo-sensitive material KONICA CORPORATION (JP) 1986-03-19 EP disclosed